Oxistat
NDC Package 21695-459-30

11-digit billing NDC: 21695045930 · Billing unit: ML

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Oxistat is ® Cream and Lotion are indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes, or Epidermophyton floccosum. Marketed by Rebel Distributors Corp., this product is identified by NDC 21695-459 and is authorized under FDA application NDA020209.

Identification & Billing

NDC Package Code
21695-459-30
Package Description
30 g in 1 TUBE
Product Code
11-Digit Billing Format
21695045930
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Oxistat
Dosage Form
-
Usage Information
OXISTAT® Cream and Lotion are indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes, or Epidermophyton floccosum. OXISTAT® Cream is indicated for the topical treatment of tinea (pityriasis) versicolor due to Malassezia furfur (see DOSAGE AND ADMINISTRATION and CLINICAL STUDIES).OXISTAT® Cream may be used in pediatric patients for tinea corporis, tinea cruris, tinea pedis, and tinea (pityriasis) versicolor; however, these indications for which OXISTAT® Cream has been shown to be effective rarely occur in children below the age of 12.

Regulatory & Marketing

Labeler Name
Rebel Distributors Corp.
FDA Application #
NDA020209
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-25-2006
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 21695-459-30 identifies a specific commercial package of 30 g in 1 tube of Oxistat, labeled by Rebel Distributors Corp.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rebel Distributors Corp. on January 25, 2006. The current certification is valid through December 31, 2017.

How is this Rebel Distributors Corp. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 21695045930. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
21695-459-30
11-Digit CMS (5-4-2)
21695-0459-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.